美国公共卫生诊所潜伏性结核感染照护级联的评估
通过结核病流行病学研究联盟在美国15个地方卫生部门结核病诊所开展队列研究,回顾2016—2017年接受潜伏性结核感染(LTBI)照护者的病历。在23885名受检者中,2877人(12%)至少一项检测阳性,2515人(11%)诊断为LTBI,其中1073人(42%)启动治疗,817人(76%)完成治疗。结论认为LTBI照护级联存在显著缺口,不足半数确诊者启动治疗。
要点
- 23885名受检者中2877人(12%)至少一项检测阳性,美国出生者3%、非美国出生者23%(P < .01)。
- 2515人(11%)诊断为LTBI,其中1073人(42%)启动治疗,817人(76%)完成治疗。
- 完成治疗者占LTBI诊断者的32%,照护级联各环节存在显著缺口。
核心结论
- LTBI照护级联各环节存在显著缺口,确诊LTBI者中不足半数启动治疗。
- 需要进一步研究以更好地刻画阻碍LTBI诊断、治疗启动和治疗完成的因素。
研究设计与样本
- 通过结核病流行病学研究联盟(TBESC)开展队列研究,覆盖美国15个地方卫生部门(LHD)结核病诊所。
- 通过病历回顾提取2016—2017年接受LTBI照护者的数据。
- 主要目标为量化从LTBI检测到治疗完成的LTBI照护级联。
主要发现
- 23885名受检者中46%(11009)为男性,中位年龄31岁(四分位距20—46)。
- 各站点美国出生者比例中位数为35%(四分位距11—78)。
- 16689人(70%)接受结核菌素皮肤试验(TST),6993人(29%)接受QuantiFERON(QFT),1934人(8%)接受T-SPOT.TB,1190人(5%)接受一种以上检测。
- 受检者中2877人(12%)至少一项检测阳性,美国出生者3%、非美国出生者23%(P < .01)。
- 全部受检者中2515人(11%)诊断为LTBI,其中1073人(42%)启动治疗,817人(76%)完成治疗,完成治疗者占LTBI诊断者的32%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis (TB) elimination within the United States will require scaling up TB preventive services. Many public health departments offer care for latent tuberculosis infection (LTBI), although gaps in the LTBI care cascade are not well quantified. An understanding of these gaps will be required to design targeted public health interventions. METHODS: We conducted a cohort study through the Tuberculosis Epidemiologic Studies Consortium (TBESC) within 15 local health department (LHD) TB clinics across the United States. Data were abstracted on individuals receiving LTBI care during 2016-2017 through chart review. Our primary objective was to quantify the LTBI care cascade, beginning with LTBI testing and extending through treatment completion. RESULTS: Among 23 885 participants tested by LHDs, 46% (11 009) were male with a median age of 31 (interquartile range [IQR] 20-46). A median of 35% of participants were US-born at each site (IQR 11-78). Overall, 16 689 (70%) received a tuberculin skin test (TST), 6993 (29%) received a Quantiferon (QFT), and 1934 (8%) received a T-SPOT.TB; 5% (1190) had more than one test. Among those tested, 2877 (12%) had at least one positive test result (3% among US-born, and 23% among non-US-born, P < .01). Of 2515 (11%) of the total participants diagnosed with LTBI, 1073 (42%) initiated therapy, of whom 817 (76%) completed treatment (32% of those with LTBI diagnosis). CONCLUSIONS: Significant gaps were identified along the LTBI care cascade, with less than half of individuals diagnosed with LTBI initiating therapy. Further research is needed to better characterize the factors impeding LTBI diagnosis, treatment initiation, and treatment completion.
引用
- Holzman SB, Perry A, Saleeb P, et al. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States. Clin Infect Dis. 2022. PMID: 35363249. doi:10.1093/cid/ciac248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。